Browse All

Current Filters

CLEAR FILTER x

TITLE

Pridopidine for the Treatment of ALS—Results from the Phase 2 Healey ALS Platform Trial

Author:Shefner, Jeremy   Oskarsson, Bjorn   Cohen, Yael   Chen, Kelly   Leitner, Melanie   Berry, James   Macklin, Eric   Chibnik, Lori   Pothier, Lindsay   Geva, Michal   Goldberg, Paul   Hayden, Michael   Paganoni, Sabrina   Cudkowicz, Merit   

Session Name:S5: ALS and CMT: New Therapeutic Approaches  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S5.003  

Author Institution:Barrow Neurological Institute, Phoenix, AZ  Mayo Clinic, Jacksonville, FL  Prilenia Therapeutics, Kibbutz Yakum, Israel  Accelerating NeuroVentures, LLC, Needham, MA  Massachusetts General Hospital, Boston, MA  Prilenia Therapeutics, Herzlyia, Israel  

The Impact of Antidopaminergic Medication on Longitudinal Clinical Progression in Huntington Disease

Author:Geva, Michal   Hand, Randal   Goldberg, Paul   Hayden, Michael   

Session Name:P6: Movement Disorders: Huntington's and Other Choreas 1  

Topic:Movement Disorders  

Program Number:P6.003  

Author Institution:Prilenia Therapeutics, Herzlyia, Israel  Prilenia Therapeutics, Kibbutz Yakum, Israel